Insulin analogues in the treatment of gestational diabetes mellitus

Clinical Obstetrics and Gynecology

Volumn 56, Issue 4, 2013, Pages 816-826

  Durnwald, Celeste P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Gestational diabetes; Insulin analogues; Insulin aspart; Insulin detemir; Insulin glargine; Insulin lispro

Indexed keywords

GLUCOSE; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; ISOPHANE INSULIN; LONG ACTING INSULIN; PIG INSULIN; SHORT ACTING INSULIN;

ARTICLE; CONGENITAL MALFORMATION; DRUG EFFICACY; DRUG SAFETY; FETOMATERNAL TRANSFUSION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; IMMUNOGENICITY; INSULIN RESISTANCE; INSULIN TREATMENT; PATIENT SATISFACTION; PERINATAL MORTALITY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; QUALITY OF LIFE;

DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN, LONG-ACTING; INSULIN, SHORT-ACTING; MATERNAL-FETAL EXCHANGE; PREGNANCY; TREATMENT OUTCOME;

EID: 84887823298     PISSN: 00099201     EISSN: 15325520     Source Type: Journal    
DOI: 10.1097/GRF.0b013e3182a8e03f     Document Type: Article

References (31)

1. McFarland MB, Langer O, Conway DL, et al. Dietary therapy for gestational diabetes: How long is long enough?. Obstet Gynecol. 1999;93: 978-982.
2. Jovanovic-Peterson L, Peterson CM, Reed GF, et al. Maternal postprandial glucose levels and infant birth weight: The Diabetes in Early Pregnancy Study. The National Institute of Child Health and Human Development - Diabetes in Early Pregnancy Study. Am J Obstet Gynecol. 1991;164:103-111.
3. Langer O, Mazze R. The relationship between large-for-gestational-Age infants and glycemic control in women with gestational diabetes. Am J Obstet Gynecol. 1988;159:1478-1483.
4. Landon MB, Gabbe SG, Piana R, et al. Neonatal morbidity in pregnancy complicated by diabetes mellitus: Predictive value of maternal glycemic profiles. Am J Obstet Gynecol. 1987;156:1089-1095.
5. Bhattacharyya A, Brown S, Hughes S, et al. Insulin lispro and regular insulin in pregnancy. QJM. 2001;94:255-260.
6. Jovanovic L, Ilic S, Pettitt DJ, et al. Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care. 1999;22:1422-1427.
7. Boskovic R, Feig DS, Derewlany L, et al. Transfer of insulin lispro across the human placenta: In vitro perfusion studies. Diabetes Care. 2003;26: 1390-1394.
8. Holcberg G, Tsadkin-TamirM, Sapir O, et al.Transfer of insulin lispro across the human placenta. Eur J Obstet Gynecol Reprod Biol. 2004;115:117-118.
9. Garg SK, Frias JP, Anil S, et al. Insulin lispro therapy in pregnancies complicated by type 1 diabetes: Glycemic control and maternal and fetal outcomes. Endocr Pract. 2003;9:187-193.
10. Masson EA, Patmore JE, Brash PD, et al. Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog). Diabet Med. 2003;20:46-50.
11. Persson B, Swahn ML, Hjertberg R, et al. Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus. Diabetes Res Clin Pract. 2002;58:115-121.
12. Wyatt JW, Frias JL, Hoyme HE, et al. Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy. Diabet Med. 2005;22:803-807.
13. Aydin Y, Berker D, Direktor N, et al. Is insulin lispro safe in pregnant women: Does it cause any adverse outcomes on infants or mothers?. Diabetes Res Clin Pract. 2008;80:444-448.
14. Cypryk K, Sobczak M, Pertynska-Marczewska M, et al. Pregnancy complications and perinatal outcome in diabetic women treated with Humalog (insulin lispro) or regular human insulin during pregnancy. Med Sci Monit. 2004;10:PI29-PI32.
15. Durnwald CP, Landon MB. A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy. J Matern Fetal Neonatal Med. 2008;21:309-313.
16. Lapolla A, Dalfra MG, Spezia R, et al. Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: An Italian experience. Acta Diabetol. 2008;45:61-66.
17. Mecacci F, Carignani L, Cioni R, et al. Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: Comparison with non-diabetic pregnant women. Eur J Obstet Gynecol Reprod Biol. 2003;111:19-24.
18. Pettitt DJ, Ospina P, Kolaczynski JW, et al. Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus. Diabetes Care. 2003;26:183-186.
19. Pettitt DJ, Ospina P, Howard C, et al. Efficacy, safety and lack of immunogenicity of insulin aspart compared with regular human insulin for women with gestational diabetes mellitus. Diabet Med. 2007;24:1129-1135.
20. Mathiesen ER, Kinsley B, Amiel SA, et al. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: A randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care. 2007;30:771-776.
21. Hod M, Damm P, Kaaja R, et al. Fetal and perinatal outcomes in type 1 diabetes pregnancy: A randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol. 2008;198:e1-e7.
22. McCance DR, Damm P, Mathiesen ER, et al. Evaluation of insulin antibodies and placental transfer of insulin aspart in pregnant women with type 1 diabetes mellitus. Diabetologia. 2008;51: 2141-2143.
23. Pollex EK, Feig DS, Lubetsky A, et al. Insulin glargine safety in pregnancy: A transplacental transfer study. Diabetes Care. 2010;33:29-33.
24. Negrato CA, Rafacho A, Negrato G, et al. Glargine vs. NPH insulin therapy in pregnancies complicated by diabetes: An observational cohort study. Diabetes Res Clin Pract. 2010;89:46-51.
25. Fang YM, MacKeen D, Egan JF, et al. Insulin glargine compared with neutral protamine hagedorn insulin in the treatment of pregnant diabetics. J Matern Fetal Neonatal Med. 2009;22: 249-253.
26. Egerman RS, Ramsey RD, Kao LW, et al. Perinatal outcomes in pregnancies managed with antenatal insulin glargine. Am J Perinatol. 2009; 26:591-595.
27. Henderson CE, Machupalli S, Marcano-Vasquez H, et al. A retrospective review of glargine use in pregnancy. J Reprod Med. 2009;54:208-210.
28. Heise T, Nosek L, Ronn BB, et al. Lower withinsubject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes. Diabetes. 2004;53: 1614-1620.
29. Lapolla A, Di Cianni G, Bruttomesso D, et al. Use of insulin detemir in pregnancy: A report on 10 Type 1 diabetic women. Diabet Med. 2009;26: 1181-1182.
30. Sciacca L, Marotta V, Insalaco F, et al. Use of insulin detemir during pregnancy. Nutr Metab Cardiovasc Dis. 2010;20:e15-e16.
31. Mathiesen ER, HodM, IvanisevicM, et al. Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care. 2012;35:2012-2117.